{"disease":{"id":"digestive-system-cancers","name":"digestive system cancers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06099821","title":"KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":39,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}